| [1] |
Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77(6):1598-1606.
|
| [2] |
Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1):188314.
|
| [3] |
Gajos-Michniewicz A, Czyz M. WNT/β-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities[J]. Genes Dis, 2024, 11(2):727-746.
|
| [4] |
Akula SM, Abrams SL, Steelman LS, et al. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma[J]. Expert Opin Ther Targets, 2019, 23(11):915-929.
|
| [5] |
Zhang HF, Gao X, Wang X, et al. The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures[J]. Biomedecine Pharmacother, 2021, 141:111868.
|
| [6] |
Hu Q, Guo C, Li Y, et al. LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration[J]. Mol Cell Biol, 2011, 31(16):3223-3240.
|
| [7] |
Karlsson T, Kvarnbrink S, Holmlund C, et al. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease[J]. Lung Cancer, 2018, 125:174-184.
|
| [8] |
He H, Li W, Yan P, et al. Identification of a recurrent LMO7-BRAF fusion in papillary thyroid carcinoma[J]. Thyroid, 2018, 28(6):748-754.
|
| [9] |
Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma[J]. Gastroenterology, 2013, 144(3):512-527.
|
| [10] |
Ooshio T, Irie K, Morimoto K, et al. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells[J]. J Biol Chem, 2004, 279(30):31365-31373.
|
| [11] |
Holaska JM, Rais-Bahrami S, Wilson KL. Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes[J]. Hum Mol Genet, 2006, 15(23):3459-3472.
|
| [12] |
Xie Y, Ostriker AC, Jin Y, et al. LMO7 is a negative feedback regulator of transforming growth factor β signaling and fibrosis[J]. Circulation, 2019, 139(5):679-693.
|
| [13] |
Liu X, Yuan H, Zhou J, et al. LMO7 as an unrecognized factor promoting pancreatic cancer progression and metastasis[J]. Front Cell Dev Biol, 2021, 9:647387.
|
| [14] |
Takahashi M, Lio CJ, Campeau A, et al. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway[J]. Nat Immunol, 2021, 22(4):485-496.
|
| [15] |
Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2):107-125.
|
| [16] |
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4):266-282.
|
| [17] |
Yao F, Deng Y, Zhao Y, et al. A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis[J]. Nat Commun, 2021, 12(1):7333.
|
| [18] |
Chen J, Li X, Ge C, et al. The multifaceted role of ferroptosis in liver disease[J]. Cell Death Differ, 2022, 29(3):467-480.
|
| [19] |
Yang WS, Zeng XF, Liu ZN, et al. Diet and liver cancer risk: a narrative review of epidemiological evidence[J]. Br J Nutr, 2020, 124(3):330-340.
|
| [20] |
Huang DQ, Singal AG, Kono Y, et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer[J]. Cell Metab, 2022, 34(7):969-977, e2.
|
| [21] |
Nevola R, Ruocco R, Criscuolo L, et al. Predictors of early and late hepatocellular carcinoma recurrence[J]. World J Gastroenterol, 2023, 29(8):1243-1260.
|
| [22] |
莫建涛，杨沛泽，曹瑞奇, 等. 基于生物信息学分析构建肝内胆管细胞癌患者铁死亡相关lncRNA预后模型[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(2):185-189.
|
| [23] |
Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress[J]. Biol Chem, 2006, 387(4):349-360.
|